Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
CRTE-7A2 by Beijing Corregene Biotechnology for Cervical Cancer: Likelihood of Approval
CRTE-7A2 is under clinical development by Beijing Corregene Biotechnology and currently in Phase I for Cervical Cancer. According to GlobalData,...
CRTE-7A2 by Beijing Corregene Biotechnology for Head And Neck Cancer: Likelihood of Approval
CRTE-7A2 is under clinical development by Beijing Corregene Biotechnology and currently in Phase I for Head And Neck Cancer. According...
CRTE-7A2 by Beijing Corregene Biotechnology for Anal Cancer: Likelihood of Approval
CRTE-7A2 is under clinical development by Beijing Corregene Biotechnology and currently in Phase I for Anal Cancer. According to GlobalData,...